Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000937
Chunk: 15

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 15
---
g) “”
means any trade price for the Depositary Shares on the Principal Market as reported by the Principal Market.

(hh) “”
means the U.S. Securities and Exchange Commission.

(ii) “”
means, collectively, the Purchase Shares and, if allotted pursuant to Section 5(e), the Commitment Shares.

(jj) “” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

(kk) “”
means any Person the Company wholly owns or controls, or in which the Company, directly or indirectly, owns a majority of the voting shares
or similar voting interest, in each case that would be disclosable pursuant to Item 601(b)(21) of Regulation S-K promulgated under the
Securities Act.

(ll) “” means, collectively, this Agreement and the schedules and exhibits hereto, the Registration Rights Agreement and
the schedules and exhibits thereto, and each of the other agreements, documents, certificates and instruments entered into or furnished
by the parties hereto in connection with the transactions contemplated hereby and thereby.

(mm) “”
means in respect of a Fixed Purchase Date, a VWAP Purchase Date and an Additional VWAP Purchase Date, as applicable, the volume weighted
average price of the Depositary Shares on the Principal Market, as reported by Bloomberg, L.P. using the AQR function.

(nn) “” means, with respect to any VWAP Purchase made pursuant to hereof, the Business Day that is the applicable
Fixed Purchase Date with respect to the corresponding Fixed Purchase referred to in clause (i) of the second sentence of
hereof.

(oo) “” means, with respect to a VWAP Purchase made pursuant to hereof, eighty-five
percent (85%) of the Closing Sale Price of the Depositary Shares on the Business Day immediately preceding the applicable Fixed Purchase
Date with respect to the corresponding Fixed Purchase referred to in clause (i) of the second sentence of hereof.

(pp) “” means, with respect to a VWAP Purchase made pursuant to hereof, an irrevocable written notice from
the Company to the Investor directing the Investor to purchase the number of Purchase Shares specified by the Company therein as the VWAP
Purchase Share Amount to be purchased by the Investor (such specified VWAP Purchase Share Amount subject to adjustment in accordance with
hereof as necessary to give effect to the Purchase Share amount limitations applicable to such VWAP Purchase Share
Amount as set forth in